ADO 5.00% 2.1¢ anteotech ltd

Fair response, but testing centres are effectively for mass...

  1. 54 Posts.
    lightbulb Created with Sketch. 75
    Fair response, but testing centres are effectively for mass screening. They were essential during the height of the pandemic, but in a future where Covid is endemic, along with the return of seasonal flu variants, then POC testing will be highly advantageous in many settings. Like I've mentioned before, there are simply some places where even just productivity lost to infectious diseases is not tolerable, let alone high risk areas where at-risk people's lives are on the line.

    Surely a hospital will want to accurately disseminate between Covid, flu, pneumonia or meningitis? Or sepsis? Aged care. Remote medical centres. The list goes on. A platform like Eugeni is superior to standalone rapid tests in just so many ways. Our biggest long term competition comes from other POC platforms. Can Anteo break into these markets? Well, after the appointment of the new Chair, I'm very optimistic this company is headed in the right direction.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.001(5.00%)
Mkt cap ! $51.84M
Open High Low Value Volume
2.0¢ 2.1¢ 1.9¢ $24.34K 1.215M

Buyers (Bids)

No. Vol. Price($)
1 6000 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 1080621 4
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.